Two Gene Therapy Players Launch IPOs on Stormy Stock Market
After a drought of more than a year, the European gene therapy sector saw initial…
After a drought of more than a year, the European gene therapy sector saw initial…
German life sciences heavyweight Evotec raised around €376M ($435M) in its US debut on the…
Oxford Nanopore Technologies, until recently one of very few unicorns in the European biotech industry,…
Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts…
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in…
The Dutch biotech startup Lava Therapeutics launched onto the Nasdaq stock market last week with…
Any biotech company that has reached a certain size and is in need of investment…
Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York…
The German company Centogene has raised €50.6M ($56M) in an IPO on the Nasdaq Stock…
The French company Innate Pharma has raised a Nasdaq IPO of €62.1M ($68.8M) to fund…
The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO,…